For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
National Review
Why Is Israel Doing Better Than Everyone Else in COVID Vaccinations?
Eleven years ago, Dan Senor and Saul Singer dubbed Israel the “Start Up Nation” for its disproportionately large number of technology start-ups and NASDAQ stock…
Blog
Employers Will Pay Workers to Get a Covid-19 Vaccine
The federal government, through Operation Warp speed, helped develop and bring to market vaccines against the new disease COVID-19 in less than a year,…
City Journal
AUDIO: Joel Zinberg Joins the 10 Blocks Podcast to Discuss COVID Vaccine Rollout
Senior Fellow Joel Zinberg joins Brian Anderson at City Journal to discuss the slow rollout of coronavirus vaccines, why states…
City Journal
End Covid Now
More than 22 million doses of Covid-19 vaccine have been distributed in the United States so far, yet only …
National Review
Why Are We Vaccinating People Who Have Recovered from COVID-19?
Now that Pfizer and Moderna have received emergency-use authorizations for their COVID-19 vaccines, the tough work of deciding how to allocate the limited supply of…
Blog
2020 Was Difficult. It Was Not the Worst Year Ever
It’s been a hard year, and I am hardly alone in being glad it’s almost over. But was 2020 the worst year ever?…